Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exudative Age-Related Macular Degeneration”

577 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 577 results

Not applicableStudy completedNCT01682382
What this trial is testing

Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular (CNV)

Who this might be right for
Age-related Macular DegenerationChoroidal Neovascular Age-related Macular Degeneration
Sequenom, Inc. 45
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Not applicableStudy completedNCT06178770
What this trial is testing

Injection Intervals in Real-world Neovascular Age-related Macular Degeneration (nAMD) Patients Switching to Brolucizumab With at Least 12 Months of Follow-up

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 414
Not applicableEnded earlyNCT05266495
What this trial is testing

Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04101877
What this trial is testing

The Sahlgrenska Anti-VEGF Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Vastra Gotaland Region 402
Not applicableStudy completedNCT07074054
What this trial is testing

Aflibercept 8 mg for nAMD: Early Anatomical and Functional Changes

Who this might be right for
Presence of Retinal FluidChanges in Macular Pigment Optical Density
Federico II University 40
Not applicableUnknownNCT03577041
What this trial is testing

Medico-economic Evaluation of Anti-VEGF Treatments in the Treatment of naïve Age-related Macular Degeneration (AMD): a Model Adapted to the French Context

Who this might be right for
Age-related Macular Degeneration (AMD)
Centre Hospitalier Universitaire, Amiens 600
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Large-scale testing (Phase 3)Temporarily pausedNCT00460967
What this trial is testing

Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

Who this might be right for
Age-Related Maculopathy
OccuLogix 325
Large-scale testing (Phase 3)Study completedNCT02157077
What this trial is testing

Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration

Who this might be right for
Macular DegenerationWet Macular DegenerationRetinal Degeneration+2 more
Centre Hospitalier Intercommunal Creteil 90
Not applicableLooking for participantsNCT07249216
What this trial is testing

Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting

Who this might be right for
Age Related Macular Degeneration
Singapore National Eye Centre 117
Early research (Phase 1)Study completedNCT00473928
What this trial is testing

Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Potentia Pharmaceuticals, Inc. 27
Large-scale testing (Phase 3)Study completedNCT02462928
What this trial is testing

A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
Allergan 939
Testing effectiveness (Phase 2)Looking for participantsNCT05672121
What this trial is testing

Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Age-Related Macular Degeneration
Chengdu Origen Biotechnology Co., Ltd. 42
Early research (Phase 1)Study completedNCT00211419
What this trial is testing

Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)

Who this might be right for
Maculopathy, Age-Related
Manhattan Eye, Ear & Throat Hospital
Not applicableActive Not RecruitingNCT06125977
What this trial is testing

Impact of Non-Exudative Type 1 MNV on AMD Progression

Who this might be right for
Age-Related Macular DegenerationNeovascularization, Choroidal
University of Utah 73
Large-scale testing (Phase 3)Ended earlyNCT04757636
What this trial is testing

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Opthea Limited 998
Not applicableStudy completedNCT01473251
What this trial is testing

Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

Who this might be right for
Exudative Macular DegenerationDiabetic Macular Edema
Vitreo-Retinal Associates, Michigan 16
Not applicableUnknownNCT00455871
What this trial is testing

Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMD

Who this might be right for
Age-Related Macular Degeneration
Barnes Retina Institute 30
Testing effectiveness (Phase 2)Ended earlyNCT02348359
What this trial is testing

X-82 to Treat Age-related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration (AMD)Macular DegenerationExudative Age-related Macular Degeneration+5 more
Tyrogenex 157
Load More Results